| Accession |
PRJCA019444 |
| Title |
SHR-1701-II-207 An open-label, multi-center phase Ib/II clinical trial of SHR-1701 combined with BP102 in the treatment of advanced solid tumors |
| Relevance |
Medical |
| Data types |
biomarker,gene data,etc
|
| Organisms |
Homo sapiens
|
| Description |
An open-label, multi-center phase Ib/II clinical trial of SHR-1701 combined with BP102 in the treatment of advanced solid tumors. |
| Sample scope |
Multiisolate |
| Release date |
2023-09-01 |
| Grants |
| Agency |
program |
Grant ID |
Grant title |
| NA
|
|
NA
|
|
|
|
| Submitter |
luchongyang
chongyang
lu (chongyang.lu@hengrui.com)
|
| Organization |
Jiangsu Hengrui Pharmaceutical Co. LTD |
| Submission date |
2023-09-01 |
